ZOETIS INC CLASS A (ZTS)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ZTS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ZTS | Former Executive Chairman of Amneal Pharmaceuticals, Inc.; Independent Director | 65 | ["Exceptional global healthcare and pharmaceutical industry expertise","Former Executive Chairman of Amneal Pharmaceuticals, Inc.","Prior senior executive leadership roles including President and CEO of Actavis","Executive Chairman of Allergan","Deep knowledge of manufacturing processes, R&D, product liability and regulatory matters","Valuable strategic M&A acumen","Legal background as a former public company general counsel","Extensive public company board experience","Strong legal and governance expertise"] | ["Corporate Governance","Quality and Innovation","Corporate Governance Committee","Quality and Innovation Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| MYGN | Former Executive Chairman, Amneal Pharmaceuticals, Inc. and President and Chief Executive Officer, Impax Laboratories, Inc.; Director | 65 | ["More than 30 years of generic and branded pharmaceutical experience","Executive Chairman of Amneal Pharmaceuticals, Inc.","President and CEO of Impax Laboratories, Inc.","Executive Chairman of Allergan, plc","President and CEO of Actavis, plc","President, Chief Operating Officer of Barr Pharmaceuticals, Inc.","General Counsel of Barr","Senior Consultant with Arthur Andersen & Co.","Undergraduate degree in General Studies from the University of Michigan","J.D. from Catholic University of America","BoardDiversity","Finance and Accounting","Leadership","HealthcareIndustry","Technology"] | ["CHCC","RPIC"] | 2026 |
| ZBH | [] | ["Audit Committee", "Compensation and Management Development Committee"] | 2017 |
Biography sourced from the proxy statement filing.
Independent Director Former Executive Chairman of Amneal Pharmaceuticals, Inc. Director since: May 2015 Committees: Corporate Governance; Quality and Innovation Age: 65 Other Current Public Company Directorships: Myriad Genetics, Inc. (since October 2022) Keenova Therapeutics plc (formerly Mallinckrodt plc) (since July 2025 and previously from 2022-June 2025) Nearly 30 years of executive leadership experience in the pharmaceutical industry, having served as executive chairman, president and chief executive officer across multiple global pharmaceutical companies including Allergan plc (formerly Actavis plc) and Amneal Pharmaceuticals, Inc. (formerly Impax Laboratories Inc.), demonstrating proven ability to lead complex organizations through periods of significant growth and transformation. Played a leading role in growing Allergan plc through, among other things, strategic M&A activity and served as Senior Vice President - Strategic Business Development, Chief Operating Officer and member of the Board of Directors at Barr Pharmaceuticals, Inc., bringing extensive deal experience and consistently identifying acquisition opportunities and market expansion possibilities to drive corporate growth. Deep expertise in pharmaceutical manufacturing operations and R&D processes, having been responsible for global manufacturing operations at Barr Pharmaceuticals, and R&D priorities that uniquely qualifying him for service on the Quality & Innovation Committee. Extensive public company board and governance expertise, currently serving on the Board of Directors of Myriad Genetics, Inc. and Keenova Therapeutics plc (formerly Mallinckrodt plc), with previous service on multiple pharmaceutical company boards, including Allergan plc (and its predecessor companies), Zimmer Biomet Holdings, Inc., Amneal Pharmaceuticals and TherapeuticsMD, Inc., and leveraging his legal background as former general counsel to provide valuable insights on corporate governance best practices and shareholder matters Career Highlights: Amneal Pharmaceuticals, Inc. (NYSE: AMRX) a global specialty pharmaceutical company Executive Chairman (2018-2019) Impax Laboratories, Inc. a specialty pharmaceutical company President and Chief Executive Officer (2017-2018) Allergan plc (formerly Actavis plc) (NYSE: AGN) a global pharmaceutical company Executive Chairman of the Board of Directors (2014-2016) Actavis (formerly Watson Pharmaceuticals) (NYSE: ACT) a global pharmaceutical company Board Chairman, President and Chief Executive Officer (2013-2014) President, Chief Executive Officer and Board Member (2007-2013) Barr Pharmaceuticals, Inc. a global specialty and generic drug manufacturer President, Chief Operating Officer and Board Member (1999-2007) Senior Vice President - Strategic Business Development (1997-1999) General Counsel (1992-1999) Education: Bachelor s degree in General Studies from the University of Michigan Juris Doctor from The Catholic University of America